Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells-Reference-Cited by-同舟云学术

Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells

Author:

Park Jong Kook¹,Seo Jung Seon²,Lee Suk Kyeong²,Chan Kenneth K³,Kuh Hyo-Jeong²⁴⁵

Affiliation:

1. Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University, Chuncheon 24252, Republic of Korea

2. Department of Biomedicine & Health Science, Graduate School, The Catholic University of Korea, Seoul 06591, Republic of Korea

3. Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA

4. Cancer Evolution Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea

5. Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea

Funder

National Research Foundation of Korea(NRF)

Ministry of Education, Science and Technology(Korean Ministry of Education, Science and Technology)

Ministry of Education(Ministry of Education of the Republic of Korea)

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

Reference60 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献